After years of reducing their contact with pharmaceutical sales representatives,physicians now risk an unintended consequence:Doctors who rarely meet with pharmaceutical sales representatives —or who do not meet with them —are much slower to drop medicines with the Food and Drug Administration’s “black box”warnings and to adopt first-in-class therapies. Newswise:MedNews [...]











































